Sterile Injection Market
Sterile Injection Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Sterile Injection Market Size and Growth
The sterile injection market is experiencing significant growth, driven by increasing demand for biologics and safety in healthcare. As of 2023, its value is estimated at approximately $50 billion, with a projected CAGR of 8% over the next five years, reflecting rising investments in innovative drug delivery systems and advanced manufacturing technologies.
Companies Covered
(Covid 19 Impact Covered)
◍ Johnson & Johnson Merck & Co.
◍ GlaxoSmithKline
◍ Gilead Sciences
◍ Baxter International
◍ Amgen
◍ Novartis AG
◍ Sanofi
◍ Pfizer
◍ Novo Nordisk A/S
◍ Merck & Co., Inc.
The sterile injection market is competitive, driven by leading companies like Johnson & Johnson, Merck & Co., and Pfizer, which contribute through innovation and product development. They enhance market growth via an expanding portfolio of biologics and advanced delivery systems. Notable sales revenues include:
- Pfizer: $81.3 billion
- Johnson & Johnson: $93.7 billion
- Merck & Co.: $59.3 billion Request Sample Report
Market Segmentation
By Application
Tumor
Cardiovascular Diseases
Infectious Disease
Diabetes
Other
By Product
◍ Monoclonal Antibodies
Insulin
Immunoglobulin
Cytokines
Blood Factors
Other
Request Sample Report
$ 73.75 Billion
Request Sample Report
